The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes

NCT01319331 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Type 1 Diabetes

Interventions

DRUG: Alpha 1-Antitrypsin (AAT, Aralast NP)

Sponsor

University of Colorado, Denver

Collaborators

[object Object]